Peer Perspectives: Economics and Real-World Data in Psychedelic Therapy Research

Matthew Hicks, ND, MS (Physician, veteran & researcher)

Thursday 25 June, 2026 8PM CEST (7PM BST, 2PM EDT, 11AM PDT)

Online via Zoom

Add to Calendar

Affordability, alternative clinical frameworks, and real-world implementation are increasingly central to the future of psychedelic-assisted therapies (PATs). This session brings together two distinct but connected areas of recent research to explore what equitable access might actually look like in practice.

The Economic Imperative: There is an urgent need for comprehensive economic evaluation and cost-effectiveness research in PATs. While clinical trials show therapeutic potential, high out-of-pocket costs currently pose a massive barrier to equitable access. Leveraging group therapy models and state-regulated programs may be key to driving impact-focused research.
Real-World Application: Putting these economic concepts into practice, Matthew will present findings from the first clinical feasibility study conducted within a state-regulated psychedelic program, evaluating group psilocybin therapy for low-income adults with depression in Oregon’s regulated program.

At a moment when psychedelic therapies are moving closer to mainstream clinical practice, this session explores ways to make them accessible to wider populations.

READY TO ATTEND?

ATTEND FOR FREE AS A MEMBER

Unlock access to this and all exclusive events with leading psychedelic experts and engage in real time through the OPEN Pro Tier Community Membership. Plus, enjoy a community space, a content library, discounts, and more.

ATTEND with donation

You can attend this event through a one-time donation to support our non-profit in organizing high-quality educational events with networking opportunities.

ABOUT THE SPEAKER

Dr. Matthew Hicks holds a doctorate in naturopathic medicine, a master of science in clinical research, and a certificate in psychedelic-assisted therapy and research. He is a Fellow of the American Board of Naturopathic Psychiatry and is a member of the Formulary Counsel of the Oregon Board of Naturopathic Medicine and the Chair of the Oregon Psilocybin Advisory Board. He is the founder and president of Synaptic Institute, a non-profit ketamine-assisted therapy clinic and entheogenic medicine training program. He is also faculty at the National University of Natural Medicine where he teaches and conducts psychedelic research.

Pro tier Member Access

As a member, you can log in below and access this event or click the button at the bottom to go to the community platform.